Skip to main content
. 2023 Feb 12;15(4):1178. doi: 10.3390/cancers15041178

Figure 3.

Figure 3

Overview of scored points according to our diagnostic model distributed in four outcome groups. The diagnostic model could discriminate excellently (p < 0.001) between the benign group (median 9.0, 25–75 percentiles 2.5–18.0 points) and the cHL group (median 78.0, 25–75 percentiles 62.0–87.0 points) and between the benign group and NHL group (median 54.0, 25–75 percentiles 40.0–65.5). The model could not discriminate between NLPHL and the benign group. Abbreviations: NHL—non-Hodgkin lymphoma; NLPHL—nodular lymphocyte-predominant Hodgkin lymphoma; cHL—classical Hodgkin lymphoma.